Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




DrStockPick.com Stock Report! 11/12/09, MON, TAXS, ISYS, FCS, ENOC, DNAB

Dr. Stock Pick (November 12th, 2009) Writes:

Dr Stock Pick HOT News & Alerts!

_______________________________________

drstock-2-3

FREE Daily Stock Alerts From DrStockPick.com

signup3m

_______________________________________

Thursday November 12, 2009

DrStockPick.com Stock Report!

**************************************************************

Monsanto Company (NYSE: MON) has completed regulatory submissions to the U.S. Department of Agriculture and U.S. Food and Drug Administration in support of the Vistive III soybean trait. This second-generation product builds on Monsanto’s existing Vistive product and would provide food companies with a healthier, more stable soybean oil for frying and baking that contains significantly lower levels of saturated fat and eliminates trans fats.

TaxMasters Inc. (OTC BB: TAXS.OB) began operational implementation this week of a proprietary system

...

Arrayit Corp. (ARYC.OB) and the USDA Join Forces to Combat Honeybee Extinction

QualityStocks (October 23rd, 2009) Writes:

Arrayit Corp., a proprietary life science technology leader for disease prevention, treatment and cure, recently announced that the U.S. Department of Agriculture (USDA) in Baton Rouge, Louisiana has purchased the company’s proprietary technology to protect America’s crop plants by combating honeybee extinction.

The USDA is utilizing Arrayit’s proprietary SpotLight microarray scanning technology and high-speed BioBlue computers to identify biomarkers in the honeybee genome to detect tracheal mites, the parasites that threaten the worldwide honeybee population. Honeybees currently pollinate approximately $14 billion worth of America’s crop plants, including fruits, seeds and vegetables, and the number of honeybees has recently decreased by up to 70 percent in some regions of the United States.

“We are pleased that the USDA is using our scanning and computing technology for this important project,” states Rene Schena, chief executive officer of Arrayit Corporation. “Arrayit is dedicated to protecting American agriculture for the benefit of farmers and consumers.”

...

Did You Hear That Big Thud?

Investment U (October 13th, 2009) Writes:

Did You Hear That Big Thud?

by Robert Williams, Publisher

It’s incredible how fast the tables can turn sometimes. Eighteen months ago, at the height of the Agriboom, supply shortages turned our nation’s farms into virtual ATMs.

Farmers couldn’t grow their respective crops fast enough. Farm incomes were pushed about 30% higher than the average wage for all workers. And thanks to the accompanying rise in property values, the average net worth of a full-time farmer mushroomed to $830,000. (U.S. farmers earned a record $80.4 billion after expenses in 2008.)

Even colleges with Agricultural majors saw big upticks in enrollment.

Well, proving again that trends typically swing back to their historical means, we recently got the latest data on farming. And it isn’t good for farmers.

The U.S. Department of Agriculture expects farm income this year –

...

GenVec’s TNFerade Nears NDA Status (NASDAQ:GNVC)

Michael Vlaicu (September 9th, 2009) Writes:

GenVec, Inc.

(Public, NASDAQ:GNVC)

StocksHaven Investments profiles a clinical stage biopharmaceutical company developing gene-based therapeutic drugs and vaccines. Its lead product candidate, TNFerade biologic (TNFerade), is being developed for use in the treatment of cancer, and is currently undergoing Phase III trials which are expected to be completed by Q1 2010. In addition to its therapeutic product development programs, GenVec is working with collaborators to develop new applications for its technology through its vaccine development programs. The Company is developing a vaccine in animal health against foot-and-mouth disease and preventative vaccines for malaria, human immunodeficiency virus (HIV), respiratory syncytial virus, and Herpes Simplex Virus Type 2 (HSV-2). Surrounded by cash infusions through grants, mutual and institutional investors, multi-purpose products with billion dollar market potential, and an already flowing revenue stream – GenVec is one company you shouldn’t pass by.

About

Genvec

...
Tags for this Post:
adenovector delivery, adenovector delivery technology, adenovector technology, adenovector vaccine candidate, adenovirus, Agricultural Research Service, Allergy, America, Analyst, and Lead Investment Analyst, antibodies, Antigenics Inc., Apple Inc, Associate Professor, balance disorders, bank of america corp, Barclays, Biotechnology, California, cancer, Cancer Research, Cancers, care for patients with balance disorders, ceo, Chemotherapy, clinical disease, Dendreon Corporation;, director, Douglas J. Swirsky, esophageal cancer, Executive Vice President, Executive Vice President of Research and Development, Fda, fibrosis;, Food Supply, foot-and-mouth disease, founder, Gaithersburg;, gene expression, gene therapy, GenVec Inc., Head And Neck Cancer, hearing loss;, HIV, Infectious Diseases, Laszlo Zsak, lead therapeutic product candidate, locally advanced pancreatic cancer, Major, Malaria, manager, Marvin Grubman, Maryland, meat products, Michael Vlaicu;, multi-purpose products, National Institute of Allergy, National Institute of Allergy and Infectious Diseases of the National Institutes of Health, Naval Medical Research Center, necrosis, Oncologix Inc., Pancreatic Cancer, parasitic disease, Patrick Swazy, Paul H. Fischer, Pfizer Inc, Ph.D., Pharmaceutical, Plum Island Animal Disease Center, president and chief executive officer, Professor of Human Oncology, Q1, radiation, rectal cancer, Researchers of the Livestock Sciences, Reuters, Royce Micro, SAIC-Frederick Inc., San Francisco, second-generation vaccine candidate, Spartan Micro, stage biopharmaceutical;, Steve Jobs, Stocks to Watch, targeted radiation therapy, therapy for locally advanced pancreatic cancer, TherAtoh, TNFerade;, TNFerade™;, transcriptional start site, treatment of inoperable, treatment of locally advanced pancreatic cancer;, treatment of pancreatic cancer, treatment of various cancers;, tumor, tumors, U.S. Department of Agriculture, U.S. Food and Drug Administration, United Kingdom, United States, University of California at San Francisco, University of California Irvine Comprehensive Digestive Disease Center, University of Denver, University Of Wisconsin, USD, USDA, vaccine candidate, Vaccine Research Center, Vaccine Research Center/National Institute, Vaccines, Vice President and Chief Financial Officer, Vice President of Research and Development, Wisconsin, Yahoo, yale, Yale University School of Medicine

Corn Crop Numbers Boost Ethanol Producers

Investment U (July 29th, 2009) Writes:

Corn Crop Numbers Boost Ethanol Producers

by The Investment U Research Team

The reports coming out from the U.S. Department of Agriculture suggest that this year’s corn crop could be a record breaker. If conditions hold, 2009 could be one of the best corn crops of the past thirty years.

And that’s a good thing for ethanol producers.

A majority of the ethanol industry is still in shambles from the collapse of oil prices. Companies have been crippled by a laundry list of issues – many self-inflicted: misjudged corn hedging, over expansion, and dependence upon government regulation.

However, at the end of the day, cheap corn spells increased profits for ethanol producers. A big crop mean low corn prices, and you can already see the impact on some of the more well-known ethanol companies.

Green Plains Renewable Energy (Nasdaq:

...

Use Your “Bean” to Profit

Investment U (July 1st, 2009) Writes:

Use Your “Bean” to Profit

Tony Daltorio, The Investment U Research Team

At times it is extremely easy to make money in the financial markets. All it takes is a bit of common sense and using your head – your “bean”.

For instance, there is a basic truism – people need to eat. Yet investors, including many on Wall Street, ignore that truism and go off in search of the next trendy hot technology stock or unproven miracle stock.

Perhaps they think people can exist simply on their Blackberry or iPhone and no longer to eat food.

I am here to tell you that people still do indeed eat food, lots of it, every day. After a year about worrying about their piggy bank, some alert investors are turning their attention again to the cupboard. And, oh my, the cupboard

...

Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.